New device aims to prevent dangerous blood pressure drops during surgery
NCT ID NCT07554599
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a non-invasive device called the Hypotension Prediction Index (HPI) in 60 elderly patients (ages 65-90) undergoing shoulder surgery in a beach chair position. The device predicts when blood pressure might drop dangerously low, allowing doctors to intervene early. The goal is to reduce brain oxygen drops and complications like stroke or kidney injury.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
non-invasive Hypotension Prediction Index (HPI) device
What this could lead to
If successful, this device could help doctors prevent dangerous drops in blood pressure during surgery, reducing the risk of brain injury and other complications in elderly patients.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to all patients. The device may not reliably predict hypotension or improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THE INTRAOPERATIVE HYPOTENSIONN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••